Address	First Canadian Place, 34th Floor Toronto Ontario M5X 1A9 Canada
Employees	-
Website	http://vxlbio.com
Updated	07/08/2019
Vaxil Bio Ltd. engages in the development of immunotheraphies such as neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on September 13, 2013 and is headquartered in Toronto, Canada.